SARS-COV-2 AND INFLUENZA CO-INFECTION: FAIR COMPETITION OR SINISTER COMBINATION?


ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

Elotuzumab, targeting signaling lymphocytic activation molecule family 7 (SLAMF7), has been approved in combination with lenalidomide and dexamethasone (ELd) for relapsed/refractory multiple myeloma (MM) based on the findings of the phase III randomized trial ELOQUENT-2 (NCT01239797).Four-year follow-up analyses of ELOQUENT-2 have demonstrated that

read more



Tingkat Kecanduan Internet pada Remaja Awal

This study shows that there are students who have an Internet addiction.Addictions possessed by students will certainly have a negative impact on self, social relationships and learning outcomes.This study aims to describe: 1) The level of Internet addiction in general 2) The core click here symptoms of Internet addiction in early adolescents 3) Pr

read more